Reddy JK, Hashimoto T. Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system. Ann Rev Nutr. 2001;21:193–230.

CAS  Article  Google Scholar 

Waterham HR, Ferdinandusse S, Wanders RJA. Human disorders of peroxisome metabolism and biogenesis. BBA-Mol Cell Res. 2016;1863:922–33.

CAS  Google Scholar 

Ferdinandusse S, Kostopoulos P, Denis S, Rusch H, Overmars H, Dillmann U, Reith W, Haas D, Wanders RJA, Duran M, Marziniak M. Mutations in the gene encoding peroxisomal sterol carrier protein X (SCPx) cause leukencephalopathy with dystonia and motor neuropathy. Am J Hum Genet. 2006;78:1046–52.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Horvath R, Lewis-Smith D, Douroudis K, Duff J, Keogh M, Pyle A, Fletcher N, Chinnery PF. SCP2 mutations and neurodegeneration with brain iron accumulation. Neurology. 2015;85:1909–11.

PubMed  PubMed Central  Article  Google Scholar 

Li NC, Fan JJ, Papadopoulos V. Sterol carrier protein-2, a nonspecific lipid-transfer protein, in intracellular cholesterol trafficking in testicular Leydig cells. PLoS ONE. 2016;11:e0149728.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Gallegos AM, Atshaves BP, Storey SM, McIntosh AL, Petrescu AD, Schroeder F. Sterol carrier protein-2 expression alters plasma membrane lipid distribution and cholesterol dynamics. Biochemistry. 2001;40:6493–506.

CAS  PubMed  Article  Google Scholar 

Puglielli L, Rigotti A, Greco AV, Santos MJ, Nervi F. Sterol carrier protein-2 is invovled in cholesterol transfer from the endoplasmic-reticulum to the plasma membrane in human fibrobalsts. J Biol Chem. 1995;270:18723–6.

CAS  PubMed  Article  Google Scholar 

Gadella TWJ, Wirtz KWA. The low-affinity lipid-binding site of the nonspecific lipid transfer protein: implications for its mode of action. Biochem Biophys Acta. 1991;1070:237–45.

CAS  PubMed  Article  Google Scholar 

Schroeder F, Myerspayne SC, Billheimer JT, Wood WG. Probing the ligand-binding sites of fatty acid and sterol carrier proteins: effects of ethanol. Biochemistry. 1995;34:11919–27.

CAS  PubMed  Article  Google Scholar 

Stolowich NJ, Frolov A, Atshaves B, Murphy EJ, Jolly CA, Billheimer JT, Scott AI, Schroeder F. The sterol carrier protein-2 fatty acid binding site: An NMR, circular dichroic, and fluorescence spectroscopic determination. Biochemistry. 1997;36:1719–29.

CAS  PubMed  Article  Google Scholar 

Frolov A, Miller K, Billheimer JT, Cho TH, Schroeder F. Lipid specificity and location of the sterol carrier protein-2 fatty acid-binding site: A fluorescence displacement and energy transfer study. Lipids. 1997;32:1201–9.

CAS  PubMed  Article  Google Scholar 

Gallegos AM, Atshaves BP, Storey SM, Starodub O, Petrescu AD, Huang H, McIntosh AL, Martin GG, Chao H, Kier AB, Schroeder F. Gene structure, intracellular localization, and functional roles of sterol carrier protein-2. Prog Lipid Res. 2001;40:498–563.

CAS  PubMed  Article  Google Scholar 

Seedorf U, Raabe M, Ellinghaus P, Kannenberg F, Fobker M, Engel T, Denis S, Wouters F, Wirtz KWA, Wanders RJA, et al. Defective peroxisomal catabolism of branched fatty acyl coenzyme A in mice lacking the sterol carrier protein-2 sterol carrier protein-x gene function. Genes Dev. 1998;12:1189–201.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Frolov A, Cho TH, Billheimer JT, Schroeder F. Sterol carrier protein-2, a new fatty acyl coenzyme a-binding protein. J Biol Chem. 1996;271:31878–84.

CAS  PubMed  Article  Google Scholar 

Schroeder F, Atshaves BP, McIntosh AL, Gallegos AM, Storey SM, Parr RD, Jefferson JR, Ball JM, Kier AB. Sterol carrier protein-2: new roles in regulating lipid rafts and signaling. BBA-Mol Cell Biol L. 2007;1771:700–18.

CAS  Google Scholar 

Keller GA, Scallen TJ, Clarke D, Maher PA, Krisans SK, Singer SJ. Subcellular-localizations of steroi carrier protein-2 in rat hepatocytes: its primary localization to peroxisomes. J Cell Biol. 1989;108:1353–61.

CAS  PubMed  Article  Google Scholar 

Nordgren M, Wang B, Apanasets O, Fransen M. Peroxisome degradation in mammals: mechanisms of action, recent advances, and perspectives. Front Physiol. 2013;4:145.

PubMed  PubMed Central  Article  Google Scholar 

Bougarne N, Weyers B, Desmet SJ, Deckers J, Ray DW, Staels B, De Bosscher K. Molecular actions of PPARα in lipid metabolism and inflammation. Endocr Rev. 2018;39:760–802.

PubMed  Article  Google Scholar 

Ellinghaus P, Wolfrum C, Assmann G, Spener F, Seedorf U. Phytanic acid activates the peroxisome proliferator-activated receptor alpha (PPARalpha) in sterol carrier protein 2-/ sterol carrier protein x-deficient mice. J Biol Chem. 1999;274:2766–72.

CAS  PubMed  Article  Google Scholar 

Chiang JY. Bile acids: regulation of synthesis. J Lipid Res. 2009;50:1955–66.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Yunfeng C, Zhonglian L, Erpeng Z, Ju Z, Naiqiang C. Increased bile lithogenicity by SCP2 via HMGCR and CYP7A1 regulation in human hepatocytes. Turk J Gastroenterol. 2013;24:241–50.

PubMed  Article  Google Scholar 

Miller WL. Steroidogenic acute regulatory protein (StAR), a novel mitochondrial cholesterol transporter. Biochim Biophys Acta. 2007;1771:663–76.

CAS  PubMed  Article  Google Scholar 

Alessenko AV, Albi E. Exploring sphingolipid implications in neurodegeneration. Front Neurol. 2020;11:437.

PubMed  PubMed Central  Article  Google Scholar 

Taniguchi M, Okazaki T. Ceramide/sphingomyelin rheostat regulated by sphingomyelin synthases and chronic diseases in murine models. J Lipid Atheroscler. 2020;9:380–405.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Rosenson RS. Fenofibrate: treatment of hyperlipidemia and beyond. Expert Rev Cardiovasc Ther. 2008;6:1319–30.

CAS  PubMed  Article  Google Scholar 

Dansen TB, Kops GJ, Denis S, Jelluma N, Wanders RJ, Bos JL, Burgering BM, Wirtz KW. Regulation of sterol carrier protein gene expression by the forkhead transcription factor FOXO3a. J Lipid Res. 2004;45:81–8.

CAS  PubMed  Article  Google Scholar 

Howaldt A, Hennig AF, Rolvien T, Rössler U, Stelzer N, Knaus A, Böttger S, Zustin J, Geißler S, Oheim R, et al. Adult osteosclerotic metaphyseal dysplasia with progressive osteonecrosis of the jaws and abnormal bone resorption pattern due to a LRRK1 splice site mutation. J Bone Miner Res. 2020;35:1322–32.

CAS  PubMed  Article  Google Scholar 

Nishimura G, Kozlowski K. Osteosclerotic metaphyseal dysplasia. Pediatr Radiol. 1993;23:450–2.

CAS  PubMed  Article  Google Scholar 

Schulte EC, Ellwanger DC, Dihanich S, Manzoni C, Stangl K, Schormair B, Graf E, Eck S, Mollenhauer B, Haubenberger D, et al. Rare variants in LRRK1 and Parkinson’s disease. Neurogenetics. 2014;15:49–57.

CAS  PubMed  Article  Google Scholar 

Blomqvist M, Smeland MF, Lindgren J, Sikora P, Riise Stensland HMF, Asin-Cayuela J. β-Mannosidosis caused by a novel homozygous intragenic inverted duplication in. Cold Spring Harb Mol Case Stud. 2019;5:a003954.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Safka Brozkova D, Varga L, Uhrova Meszarosova A, Slobodova Z, Skopkova M, Soltysova A, Ficek A, Jencik J, Lastuvkova J, Gasperikova D, Seeman P. Variant c.2158–2A>G in MANBA is an important and frequent cause of hereditary hearing loss and beta-mannosidosis among the Czech and Slovak Roma population- evidence for a new ethnic-specific variant. Orphanet J Rare Dis. 2020;15:222.

PubMed  PubMed Central  Article  Google Scholar 

Scheinman SJ, Guay-Woodford LM, Thakker RV, Warnock DG. Genetic disorders of renal electrolyte transport. N Engl J Med. 1999;340:1177–87.

CAS  PubMed  Article  Google Scholar 

Scheinman SJ. X-linked hypercalciuric nephrolithiasis: clinical syndromes and chloride channel mutations. Kidney Int. 1998;53:3–17.

CAS  PubMed  Article  Google Scholar 

Lloyd SE, Pearce SH, Fisher SE, Steinmeyer K, Schwappach B, Scheinman SJ, Harding B, Bolino A, Devoto M, Goodyer P, et al. A common molecular basis for three inherited kidney stone diseases. Nature. 1996;379:445–9.

CAS  PubMed  Article  Google Scholar 

Boerman RH, Ophoff RA, Links TP, van Eijk R, Sandkuijl LA, Elbaz A, Vale-Santos JE, Wintzen AR, van Deutekom JC, Isles DE. Mutation in DHP receptor alpha 1 subunit (CACLN1A3) gene in a Dutch family with hypokalaemic periodic paralysis. J Med Genet. 1995;32:44–7.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Buruma OJ, Bots GT, Went LN. Familial hypokalemic periodic paralysis: 50-year follow-up of a large family. Arch Neurol. 1985;42:28–31.

CAS  PubMed  Article  Google Scholar 

Miller TM, Dias da Silva MR, Miller HA, Kwiecinski H, Mendell JR, Tawil R, McManis P, Griggs RC, Angelini C, Servidei S, et al. Correlating phenotype and genotype in the periodic paralyses. Neurology. 2004;63:1647–55.

CAS  PubMed  Article